Stock Events

Stock Events

Viking Therapeutics (1VT.XETRA) Q2 2026 Earnings

29AprConfirmed

Q2 2026

-1.17

-1.06

-0.95

-0.84

Details

Expected EPS

-0.83536621728

Actual EPS

-1.1731036000000001

Surprise EPS

-0.34

Surprise Percent

+40.43%

Description

Viking Therapeutics (1VT.XETRA) has reported earnings of -1.1731036000000001 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.